Gene · 5987
Papers2,241
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,241
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A human-derived neurovascular unit in vitro model to study the effects of cellular cross-talk and soluble factors on barrier integrity. | Front Cell Neurosci | 2022 | 36545654 | PubTator, text mining | PubMed |
| Epigenetics of type 2 diabetes and diabetes-related outcomes in the Strong Heart Study. | Clin Epigenetics | 2022 | 36529747 | PubTator, text mining | PubMed |
| Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors. | J Transl Med | 2022 | 36528667 | PubTator, text mining | PubMed |
| TRIM27 is an adverse prognostic biomarker and associated with immune and molecular profiles in right-sided colon cancer. | Am J Cancer Res | 2022 | 36504896 | PubTator, text mining | PubMed |
| Multi-Omics Immune Interaction Networks in Lung Cancer Tumorigenesis, Proliferation, and Survival. | Int J Mol Sci | 2022 | 36499305 | PubTator, text mining | PubMed |
| E3 Ubiquitin Ligases: The Operators of the Ubiquitin Code That Regulates the RLR and cGAS-STING Pathways. | Int J Mol Sci | 2022 | 36498930 | PubTator, text mining | PubMed |
| Live imaging of apoptotic signaling flow using tunable combinatorial FRET-based bioprobes for cell population analysis of caspase cascades. | Sci Rep | 2022 | 36476686 | PubTator, text mining | PubMed |
| Prognostic value of tripartite motif (TRIM) family gene signature from bronchoalveolar lavage cells in idiopathic pulmonary fibrosis. | BMC Pulm Med | 2022 | 36474231 | PubTator, text mining | PubMed |
| TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein. | J Exp Clin Cancer Res | 2022 | 36471347 | PubTator, text mining | PubMed |
| Rescue of an enterotropic Newcastle disease virus strain ZM10 from cloned cDNA and stable expressing an inserted foreign gene. | BMC Biotechnol | 2022 | 36471312 | PubTator, text mining | PubMed |
| Tuning the Ferroelectric Phase Transition of P(VDF-TrFE) through a Simple Approach of Modification by Introducing Double Bonds. | ACS Omega | 2022 | 36467914 | PubTator, text mining | PubMed |
| Expansion of the mutation spectrum and phenotype of USP7-related neurodevelopmental disorder. | Front Mol Neurosci | 2022 | 36466803 | PubTator, text mining | PubMed |
| Pan-cancer illumination of TRIM gene family reveals immunology regulation and potential therapeutic implications. | Hum Genomics | 2022 | 36461099 | PubTator, text mining | PubMed |
| Eribulin normalizes pancreatic cancer-associated fibroblasts by simulating selected features of TGFβ inhibition. | BMC Cancer | 2022 | 36461015 | PubTator, text mining | PubMed |
| Cross-regulome profiling of RNA polymerases highlights the regulatory role of polymerase III on mRNA transcription by maintaining local chromatin architecture. | Genome Biol | 2022 | 36443871 | PubTator, text mining | PubMed |
| Small and mighty - microRNAs pulling the strings. | Biomed J | 2022 | 36442792 | PubTator, text mining | PubMed |
| A 69 kb Deletion in chr19q13.42 including PRPF31 Gene in a Chinese Family Affected with Autosomal Dominant Retinitis Pigmentosa. | J Clin Med | 2022 | 36431159 | PubTator, text mining | PubMed |
| Targeting PTEN Regulation by Post Translational Modifications. | Cancers (Basel) | 2022 | 36428706 | PubTator, text mining | PubMed |
| Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer. | Front Immunol | 2022 | 36405739 | PubTator, text mining | PubMed |
| SLFN11 negatively regulates non-canonical NFkB signaling to promote glioblastoma progression. | Cancer Res Commun | 2022 | 36382088 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5987/papers?page=16